S. Curescu

Prospective molecular marker analyses of EGFR and KRAS from a randomized, placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer.

F. Cappuzzo, W. Brugger, N. Triller, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effectiveness and safety profile of ipilimumab therapy in previously treated patients with unresectable or metastatic melanoma - the Romanian Patient Access Program.

T. Ciuleanu, S. Curescu, C. Aldea, 2017, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Biomarker analyses from the phase III placebo-controlled SATURN study of maintenance erlotinib following first-line chemotherapy for advanced NSCLC.

F. Cappuzzo, W. Brugger, N. Triller, 2009, Journal of Clinical Oncology.

Prospective molecular marker analyses of EGFR and KRAS from a randomized, placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer.

F. Cappuzzo, W. Brugger, N. Triller, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.